about
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Dr...
Read More
29.43
-0.57
(-1.90%)
1.8M
XNAS Volume
XNAS 30 Jan, 2026 4:30 PM (EST)
Medium Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have average quality, financial and technical momentum, indicating a mid range performer
View Similar
Embed DVM
TG Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..